Tech Company Financing Transactions
Qvella Funding Round
Qvella closed a $20 million Series A funding round on 10/30/2015. Investors included RA Capital and private investors.
Transaction Overview
Company Name
Announced On
10/30/2015
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
RA Capital (Lead Investor) (Parker Cassidy)
Proceeds Purpose
This latest round of funding provides us with the capital to support our ongoing research and development, and build out our team. It also gives us access to strong investment partners who will provide strategic guidance and back our future growth.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9133 Leslie St. 110
Richmond Hill ON, L4B 4N1
Canada
Richmond Hill ON, L4B 4N1
Canada
Phone
Website
Email Address
Not Recorded
Overview
Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology. The company has developed a highly differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tino Alavie
Chief Scientific Officer
Samad Talebpour
VP - Bus. Development
Glenn Magnuson
VP - Marketing
Stephen Clark
VP - Product Management
Robert Maaskant
VP - Regulatory Affairs
Susan Novak-Weekley
Browse more venture capital transactions:
Prev: 10/30/2015: TrendKite venture capital transaction
Next: 10/30/2015: SignalSense venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs